Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-21-001527

Director sold 4,000 shares at $76.08 ($304,320)

  • Director acquired 9,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

GIVEN DOUGLAS B · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-01 Grant or award : show line 1 in the form +9,500 123,368 D
2021-01-04 Sale : show line 2 in the form −4,000 $76.08 $304,320 119,368 D
Open-market sales · 4,000 sh · avg $76.08 · $304,320
Loading xslF345X03/doc4.xml…